HAEMONETICS CORP/MASS (HAE) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:HAE • US4050241003
65.94 USD
-0.72 (-1.08%)
Last: Feb 2, 2026, 03:48 PM
Overall HAE gets a fundamental rating of 5 out of 10. We evaluated HAE against 186 industry peers in the Health Care Equipment & Supplies industry. While HAE has a great profitability rating, there are some minor concerns on its financial health. HAE is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
- HAE had positive earnings in the past year.
- HAE had a positive operating cash flow in the past year.
- HAE had positive earnings in each of the past 5 years.
- Each year in the past 5 years HAE had a positive operating cash flow.
1.2 Ratios
- With an excellent Return On Assets value of 6.89%, HAE belongs to the best of the industry, outperforming 88.17% of the companies in the same industry.
- With an excellent Return On Equity value of 19.81%, HAE belongs to the best of the industry, outperforming 94.09% of the companies in the same industry.
- HAE has a Return On Invested Capital of 10.48%. This is amongst the best in the industry. HAE outperforms 89.78% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for HAE is in line with the industry average of 8.81%.
- The 3 year average ROIC (8.96%) for HAE is below the current ROIC(10.48%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.89% | ||
| ROE | 19.81% | ||
| ROIC | 10.48% |
ROA(3y)6.05%
ROA(5y)4.97%
ROE(3y)15.59%
ROE(5y)12.69%
ROIC(3y)8.96%
ROIC(5y)7.22%
1.3 Margins
- Looking at the Profit Margin, with a value of 12.67%, HAE belongs to the top of the industry, outperforming 89.25% of the companies in the same industry.
- In the last couple of years the Profit Margin of HAE has grown nicely.
- With an excellent Operating Margin value of 19.11%, HAE belongs to the best of the industry, outperforming 91.94% of the companies in the same industry.
- In the last couple of years the Operating Margin of HAE has remained more or less at the same level.
- With a Gross Margin value of 58.46%, HAE perfoms like the industry average, outperforming 59.14% of the companies in the same industry.
- HAE's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.11% | ||
| PM (TTM) | 12.67% | ||
| GM | 58.46% |
OM growth 3Y21.18%
OM growth 5Y0.48%
PM growth 3Y41.28%
PM growth 5Y9.75%
GM growth 3Y1.97%
GM growth 5Y2.6%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HAE is creating some value.
- HAE has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for HAE has been reduced compared to 5 years ago.
- The debt/assets ratio for HAE is higher compared to a year ago.
2.2 Solvency
- HAE has an Altman-Z score of 2.43. This is not the best score and indicates that HAE is in the grey zone with still only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.43, HAE is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
- HAE has a debt to FCF ratio of 5.76. This is a neutral value as HAE would need 5.76 years to pay back of all of its debts.
- With a decent Debt to FCF ratio value of 5.76, HAE is doing good in the industry, outperforming 77.42% of the companies in the same industry.
- A Debt/Equity ratio of 1.08 is on the high side and indicates that HAE has dependencies on debt financing.
- With a Debt to Equity ratio value of 1.08, HAE is not doing good in the industry: 75.81% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.08 | ||
| Debt/FCF | 5.76 | ||
| Altman-Z | 2.43 |
ROIC/WACC1.16
WACC9.07%
2.3 Liquidity
- A Current Ratio of 1.64 indicates that HAE should not have too much problems paying its short term obligations.
- With a Current ratio value of 1.64, HAE is not doing good in the industry: 70.43% of the companies in the same industry are doing better.
- A Quick Ratio of 1.03 indicates that HAE should not have too much problems paying its short term obligations.
- HAE has a Quick ratio of 1.03. This is in the lower half of the industry: HAE underperforms 73.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.64 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 17.65% over the past year.
- The Earnings Per Share has been growing slightly by 6.66% on average over the past years.
- Looking at the last year, HAE shows a decrease in Revenue. The Revenue has decreased by -2.45% in the last year.
- The Revenue has been growing slightly by 6.60% on average over the past years.
EPS 1Y (TTM)17.65%
EPS 3Y20.84%
EPS 5Y6.66%
EPS Q2Q%13.39%
Revenue 1Y (TTM)-2.45%
Revenue growth 3Y11.07%
Revenue growth 5Y6.6%
Sales Q2Q%-5.27%
3.2 Future
- Based on estimates for the next years, HAE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.57% on average per year.
- HAE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.33% yearly.
EPS Next Y8.59%
EPS Next 2Y9.96%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue Next Year-3.06%
Revenue Next 2Y1.3%
Revenue Next 3Y3.33%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 13.74, HAE is valued correctly.
- Compared to the rest of the industry, the Price/Earnings ratio of HAE indicates a rather cheap valuation: HAE is cheaper than 90.32% of the companies listed in the same industry.
- HAE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.32.
- A Price/Forward Earnings ratio of 11.93 indicates a reasonable valuation of HAE.
- Based on the Price/Forward Earnings ratio, HAE is valued cheaper than 92.47% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of HAE to the average of the S&P500 Index (25.57), we can say HAE is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.74 | ||
| Fwd PE | 11.93 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, HAE is valued cheaply inside the industry as 89.25% of the companies are valued more expensively.
- 95.16% of the companies in the same industry are more expensive than HAE, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.52 | ||
| EV/EBITDA | 11 |
4.3 Compensation for Growth
- HAE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- HAE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.6
PEG (5Y)2.06
EPS Next 2Y9.96%
EPS Next 3Y10.57%
5. Dividend
5.1 Amount
- No dividends for HAE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
HAEMONETICS CORP/MASS / HAE FAQ
What is the ChartMill fundamental rating of HAEMONETICS CORP/MASS (HAE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HAE.
Can you provide the valuation status for HAEMONETICS CORP/MASS?
ChartMill assigns a valuation rating of 7 / 10 to HAEMONETICS CORP/MASS (HAE). This can be considered as Undervalued.
What is the profitability of HAE stock?
HAEMONETICS CORP/MASS (HAE) has a profitability rating of 8 / 10.
Can you provide the expected EPS growth for HAE stock?
The Earnings per Share (EPS) of HAEMONETICS CORP/MASS (HAE) is expected to grow by 8.59% in the next year.